 IBTimes.co.uk |
AstraZeneca Loses US Patent Protection for Asthma Drug
Fox Business A patent protecting AstraZeneca's (AZN) Pulmicort Respules asthma drug in the U.S. was deemed invalid on Tuesday, paving the way for a generic version of the drug to hit store shelves. The company said on Tuesday a district court in New Jersey ruled in … AstraZeneca Loses US Patent on Asthma Drug US court blow for AstraZeneca on asthma drug Teva loses exclusivity on AstraZeneca asthma drug |
View full post on asthma – Google News